Copyright
©The Author(s) 2021.
World J Gastroenterol. Aug 28, 2021; 27(32): 5404-5423
Published online Aug 28, 2021. doi: 10.3748/wjg.v27.i32.5404
Published online Aug 28, 2021. doi: 10.3748/wjg.v27.i32.5404
Figure 4 Recombinant human angiopoietin-like protein 4 suppresses the intestinal inflammatory response and oxidation stress after intestinal ischemia-reperfusion.
A-E: Intestinal cytokine tumor necrosis factor-alpha (TNF-α) (A), interleukin (IL)-1β (B), interleukin-6 (C), intestinal myeloperoxidase (MPO) (D) and malondialdehyde (MDA) (E) levels in different groups (mean ± SD, n = 8). aP < 0.05, bP < 0.01 vs sham; cP < 0.05 vs ischemia-reperfusion (I/R).
- Citation: Wang ZY, Lin JY, Feng YR, Liu DS, Zhao XZ, Li T, Li SY, Sun JC, Li SF, Jia WY, Jing HR. Recombinant angiopoietin-like protein 4 attenuates intestinal barrier structure and function injury after ischemia/reperfusion. World J Gastroenterol 2021; 27(32): 5404-5423
- URL: https://www.wjgnet.com/1007-9327/full/v27/i32/5404.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i32.5404